Fundraising Fox
/People
Sign in

Abel Ureta-Vidal

Former Venture Partner at Nina Capital

Cambridge, United Kingdom

Writes $10M – $50M checks · typically $25M

Find your path to Abel

526 people in our graph can introduce you to Abel.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jonathan Milner to introduce you to Abel

You →Jonathan · together at Eagle Genomics Ltd. (2013–2020) →Abel

Ask Jamie Chen to introduce you to Abel

You →Jamie · 3 people · together at Eagle Genomics Ltd. →Abel

Ask Sam Okafor to introduce you to Abel

You →Sam · together at European Bioinformatics Institute | EMBL-EBI →Abel

Sign up to find every way you can get introduced to Abel

  • Your email: the people you already email who know Abel
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Abel
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Abel Ureta-Vidal holds a PhD in molecular biology and immunovirology from the Pasteur Institute and has worked across life sciences and digital fields since the early 1990s, including roles at Genoscope on the human genome project and at the European Bioinformatics Institute leading comparative genomics research. He founded Eagle Genomics in 2008 and served on its executive team for 12 years, expanding the company's work from pharma and biotech into plant breeding, animal health, consumer goods, and food safety. Since 2020, he has worked in venture investment as Investment Director at CMS Ventures and Venture Partner at Nina Capital while mentoring founders and advising early-stage companies in the life sciences sector.

Experience

  1. Dassault SystèmesIndustry Business Consultant - Life Sciences in the EMEA Solution Consulting teamcurrent2025 — presentCambridge, England, United Kingdom
  2. OctiocorAdviser2025Cambridgeshire, England, United Kingdom
  3. OctiocorChief Executive Officer2023 — 2025Cambridge, England, United Kingdom
  4. OctiocorBusiness Strategy Adviser2022Cambridge, England, United Kingdom
  5. Genomic Data Infrastructure (GDI)Member of the Long Term Sustainability Board (LTSB)2023 — 2025
  6. sofi.healthNon Executive Director & Data Strategy Adviser2023 — 2025London Area, United Kingdom
  7. sofi.healthChief Data Officer & Co-Founder2020 — 2023London, England, United Kingdom
  8. Nina CapitalVenture Partner2021 — 2024Barcelona, Catalonia, Spain
  9. Nanograb (YC S23)Adviser2023 — 2024London, England, United Kingdom
  10. Nanograb (YC S23)Non Executive Director2023London Area, United Kingdom
  11. Nanograb (YC S23)Mentor2021 — 2022London Area, United Kingdom
  12. FAIRplusMember of the FAIRplus Scientific and Industry Advisory Board (SIAB)2019 — 2022
  13. ELIXIRChair of the Elixir Industry Advisory Committee (IAC)2018 — 2022Cambridge, England, United Kingdom
  14. CMS VenturesInvestment Director2020 — 2021Cambridge, England, United Kingdom
  15. Eagle Genomics Ltd.Chief Product Officer & Founder2018 — 2020Cambridge, United Kingdom
  16. Eagle Genomics Ltd.Chief Executive Officer & Founder2014 — 2018Cambridge, United Kingdom
  17. Eagle Genomics Ltd.COO and Founder2011 — 2014Cambridge, United Kingdom
  18. Eagle Genomics Ltd.CEO and Founder2008 — 2011Cambridge, United Kingdom
  19. BioIndustry AssociationMember of the BIA Genomics Advisory Committee (GAC)2017 — 2020London, England, United Kingdom
  20. European Bioinformatics Institute | EMBL-EBIProject Leader2001 — 2007Cambridge, England, United Kingdom
  21. Genoscope - Centre National de SéquençageScientific programmer1999 — 2001Évry, Ile-de-France, France
  22. Institut PasteurResearcher PhD Student1994 — 1999Paris, Ile-de-France, France
  23. Institut Pasteur de la GuyaneResearch Associate1993 — 1994Cayenne, French Guiana

Skills & more

Biotechnology47Bioinformatics99R&D13Lifesciences61Genomics92Technology Transfer24Molecular Biology51Strategy24Computational Biology15Data Analysis10Informatics4Biochemistry19
+12 moreDrug DiscoveryCommercializationScienceCell BiologyPharmaceutical IndustryProteomicsGeneticsClinical DevelopmentOncologyCell CultureMentoringClinical Trials

Languages English · French · Spanish

From Abel's professional profile.

Network5

Anuj Patel
Venture Partner at Nina Capital
Austin Sawyer
Investor at Nina Capital
Ferran Marti
Associate at Nina Capital
Giangiacomo Rocco
Venture Partner at Nina Capital
Helen Routh
Venture Partner at Nina Capital

Investors connected to Abel in public investor directories — a warm-intro map.

Frequently asked questions

Who is Abel Ureta-Vidal?
Abel Ureta-Vidal holds a PhD in molecular biology and immunovirology from the Pasteur Institute and has worked across life sciences and digital fields since the early 1990s, including roles at Genoscope on the human genome project and at the European Bioinformatics Institute leading comparative genomics research. He founded Eagle Genomics in 2008 and served on its executive team for 12 years, expanding the company's work from pharma and biotech into plant breeding, animal health, consumer goods, and food safety. Since 2020, he has worked in venture investment as Investment Director at CMS Ventures and Venture Partner at Nina Capital while mentoring founders and advising early-stage companies in the life sciences sector.
What check size does Abel Ureta-Vidal write?
Abel Ureta-Vidal typically writes checks of $10M – $50M.
Where did Abel Ureta-Vidal go to school?
Abel Ureta-Vidal studied at University of Cambridge (Master of Business Administration - MBA); Université Paris Cité (PhD, Immulogy); Université Paris Cité (MSc, Oncology).

Same school

Shared employers